124 related articles for article (PubMed ID: 7641743)
1. Demonstration of estrogen and progesterone receptors in breast cancers with monoclonal antibodies. Different results with enzyme-immunoassay and immunohistochemical methods.
Mink D; Hollaender M; von Tongelen B; Villena-Heinsen C; Schmidt W
Eur J Gynaecol Oncol; 1995; 16(2):81-91. PubMed ID: 7641743
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancers.
Nishimura R; Saeki T; Ohsumi S; Tani Y; Takashima S
Breast Cancer; 2007; 14(1):100-4. PubMed ID: 17245003
[TBL] [Abstract][Full Text] [Related]
4. [Human breast cancer embedded in paraffin, fixed in Bouin's fluid. Immunohistochemical analysis of estrogen and progesterone receptors].
Jacquemier J; Boudaoura T; Martin PM; Torrente M; Hassoun J
Ann Pathol; 1991; 11(4):224-30. PubMed ID: 1958256
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of sex steroid receptors in breast cancer using routine paraffin sections: comparison with frozen sections and enzyme immunoassay.
Elias JM; Margiotta M; Sexton TR; Heimann A
J Cell Biochem Suppl; 1994; 19():126-33. PubMed ID: 7823584
[TBL] [Abstract][Full Text] [Related]
6. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
Luqmani YA; Temmim L; Memon A; Ali MA; Parkar AH
Int J Cancer; 1997 May; 71(4):526-38. PubMed ID: 9178804
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
10. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.
Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M
J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603
[TBL] [Abstract][Full Text] [Related]
11. Automated immunohistochemical assay for estrogen receptor status in breast cancer using monoclonal antibody CC4-5 on the Ventana ES.
Nichols GE; Frierson HF; Boyd JC; Hanigan MH
Am J Clin Pathol; 1996 Sep; 106(3):332-8. PubMed ID: 8816590
[TBL] [Abstract][Full Text] [Related]
12. Comparison of enzyme immunoassay and immunohistochemical measurements of estrogen and progesterone receptors in breast cancer patients.
Ferrero-Poüs M; Trassard M; Le Doussal V; Hacène K; Tubiana-Hulin M; Spyratos F
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):267-75. PubMed ID: 11556756
[TBL] [Abstract][Full Text] [Related]
13. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
Kiang DT; Kollander R
J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
Thorpe SM
Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical detection of pS2 protein in paraffin sections of breast carcinoma tissue. Comparison with results of an immunoradiometry assay].
Ahr A; Scharl A; Göhring UJ; Crombach G; Stoffl M
Pathologe; 1995 Jul; 16(4):278-84. PubMed ID: 7667210
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.
Nadji M; Gomez-Fernandez C; Ganjei-Azar P; Morales AR
Am J Clin Pathol; 2005 Jan; 123(1):21-7. PubMed ID: 15762276
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy.
Ogawa Y; Moriya T; Kato Y; Oguma M; Ikeda K; Takashima T; Nakata B; Ishikawa T; Hirakawa K
Breast Cancer; 2004; 11(3):267-75. PubMed ID: 15550845
[TBL] [Abstract][Full Text] [Related]
18. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
Andersen J
Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
[TBL] [Abstract][Full Text] [Related]
19. Enzyme immunoassay of estrogen and progesterone receptors in drill biopsy specimens from breast cancer.
Noguchi S; Miyauchi K; Inaji H; Imaoka S; Koyama H
Eur J Cancer Clin Oncol; 1989 May; 25(5):809-14. PubMed ID: 2661238
[TBL] [Abstract][Full Text] [Related]
20. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
